PICKER DONALD H (Chief Science Officer) purchased 23019.0% of their position (173.33K shares) of MOLECULIN BIOTECH, INC. on the open market
Open‑market purchases signal personal conviction — classified as a major conviction buy.
P · 1 purchase
Filed: 8/5/2026ACC: 0001437749-26-025927
Officer· Chief Science Officer
Since Jul 2019
+693.33K
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
693.33K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+173.33K
Price / share
—
Trade value
—
% of position
23019.0%
8/3/2026
753.00→174.09K
Total
Net shares
+173.33K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2026 | P · Purchase | +173.33K | — | — | 23019.0% | 753.00 | 174.09K |
| Total | +173.33K | $0.00 | ||||||
Derivative Transactions1
Series I Warrants
Direct
Converts to
Common Stock
520K shares
Shares
+520K
Strike price
Held after
539.60K
Exercisable
—
8/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series I Warrants Direct | Common Stock520K shares | 8/3/2026 | P · Purchase | +520K | — | 539.60K |